Content about Port

February 11, 2013
Walgreens Infusion Services saves $850,000 in three-month period

Home nutrition support team interventions improved patient care and potentially prevented an estimated 429 hospital days over a three-month period, at a cost savings of more than $850,000, according to new data presented by Walgreens Infusion Services at the American Society for Parenteral and Enteral Nutrition Clinical Nutrition Week meeting Monday in Phoenix.

DEERFIELD, Ill. — Home nutrition support team interventions improved patient care and potentially prevented an estimated 429 hospital days over a three-month period, at a cost savings of more than $850,000, according to new data presented by Walgreens Infusion Services at the American Society for Parenteral and Enteral Nutrition Clinical Nutrition Week meeting Monday in Phoenix. 

December 27, 2012
Walgreens Infusion Services selected as a contracted provider of just-approved long-term treatment for SBS

Walgreens Infusion Services has been selected as a contracted provider of a new injectable medication that helps patients with short bowel syndrome.

DEERFIELD, Ill. — Walgreens Infusion Services has been selected as a contracted provider of a new injectable medication that helps patients with short bowel syndrome get more — or all — of their nutrients orally, reducing their dependence on intravenous parenteral nutrition, the division announced Wednesday.

October 26, 2010
Pharmaxis: Bronchitol improved symptoms among CF patients

Drug maker Pharmaxis got promising results from an investigative treatment for cystic fibrosis, the company...

BALTIMORE Drug maker Pharmaxis got promising results from an investigative treatment for cystic fibrosis, the company said.

 

Pharmaxis announced results of two six-month phase-3 trials of 643 patients receiving Bronchitol (mannitol), which the company presented last week at the North American Cystic Fibrosis Conference in Baltimore.